ESR2
protein-codingestrogen receptor 2, the group of Estrogen receptors
Gene summary
This gene encodes a member of the family of estrogen receptors and superfamily of nuclear receptor transcription factors. The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. Upon binding to 17beta-estradiol or related ligands, the encoded protein forms homo- or hetero-dimers that interact with specific DNA sequences to activate transcription. Some isoforms dominantly inhibit the activity of other estrogen receptor family members. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been fully characterized. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~253.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032590
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0032590
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007958
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0018393
Submitter: King Faisal Specialist Hospital and Research Center
Alhathal et al., 2020 (PMID: 32719396) reported a missense variant in a large male infertility cohort (n=285 infertile man and case–control fertile man). Gene is scored according to ClinGen classification. Moderate with total score of 8. Single-variant analysis (3 points), experimental evidence: Animal model (4 points) (PMID: 32703416; PMID: 18268329) and testicular expression (1 points) (PMID: 33163677 ).
Inheritance Pattern: Unknown
Disease ID:MONDO:0032590
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0032590
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Obstetric
Intervention: Endocrine
Rationale: Individuals can present with features such as primary amenorrhea, and osteoporosis, and medical management (eg, with estrogen therapy) has been described as beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ESR2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001437.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 31 | 8 | 41 | ||
| missense | 1 | 93 | 14 | 1 | 109 | |
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 5 | 5 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 1 | 0 | 104 | 45 | 9 | 159 |
Highest pathogenic variant AF is 0.0000014588339
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001428.1 | 8 | MANE Select | |
| Ensembl | ENSP00000343925.4 | 8 | MANE Select | |
| RefSeq | NP_001035365.1 | 8 | Standard | |
| RefSeq | NP_001201831.1 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| esr2a | Danio rerio | Structure: subintestinal vein Quality: aplastic abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Breast cancer - Homo sapiens (human)
- Estrogen signaling pathway - Homo sapiens (human)
- Prolactin signaling pathway - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
- Aromatase Inhibitor Pathway (Breast Cell), Pharmacodynamics
Biological Process
- negative regulation of transcription by RNA polymerase II
- regulation of transcription, DNA-templated
- transcription initiation from RNA polymerase II promoter
- signal transduction
- cell-cell signaling
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- DNA-binding transcription factor activity
- steroid hormone receptor activity
Cellular Component
- extracellular region
- nucleus
- nucleoplasm
- mitochondrion
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000341099
- Coding exons
- 8
- Length
- 253881
- Individuals with no LoFs
- 125628
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 119
- Defined
- 125747
- p
- 0.000473
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.405 | 304 | 325 | 0.937 | 0.0000196 | 3477 |
| Missense (PolyPhen) | 78 | 94.441 | 0.82591 | 1073 | ||
| Synonymous | -2.64 | 169 | 131 | 1.29 | 0.00000858 | 1036 |
| Loss of Function | 1.53 | 15 | 22.9 | 0.654 | 0.00000120 | 267 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00032 | 0.00032 | rare |
| Ashkenazi Jewish | 0.0012 | 0.0012 | notable |
| East Asian | 0.0010 | 0.0010 | notable |
| Finnish | 0.00019 | 0.00018 | rare |
| European (Non-Finnish) | 0.00043 | 0.00042 | rare |
| South Asian | 0.00070 | 0.00069 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent manner (PubMed:20074560). Isoform beta-cx lacks ligand binding ability and has no or only very low ere binding activity resulting in the loss of ligand-dependent transactivation ability. DNA-binding by ESR1 and ESR2 is rapidly lost at 37 degrees Celsius in the absence of ligand while in the presence of 17 beta-estradiol and 4-hydroxy-tamoxifen loss in DNA-binding at elevated temperature is more gradual. {ECO:0000269|PubMed:20074560}.;
Recessive Scores
- pRec
- 0.749
Intolerance Scores
- LoFtool
- 0.0411
- RVIS EVS
- -0.95
- RVIS percentile EVS
- 9.27
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.897
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |